South Korea Covid-19 Drug Delivery Devices Market Size & Outlook

The covid-19 drug delivery devices market in South Korea is expected to reach a projected revenue of US$ 42.1 million by 2027. A compound annual growth rate of -2.9% is expected of South Korea covid-19 drug delivery devices market from 2022 to 2027.
Revenue, 2021 (US$M)
$50.1
Forecast, 2027 (US$M)
$42.1
CAGR, 2022 - 2027
-2.9%
Report Coverage
South Korea

South Korea covid-19 drug delivery devices market, 2016-2027 (US$M)

South

South Korea covid-19 drug delivery devices market highlights

  • The South Korea covid-19 drug delivery devices market generated a revenue of USD 50.1 million in 2021 and is expected to reach USD 42.1 million by 2027.
  • The South Korea market is expected to grow at a CAGR of -2.9% from 2022 to 2027.
  • In terms of segment, prefilled syringe was the largest revenue generating product in 2021.
  • Inhalers is the most lucrative product segment registering the fastest growth during the forecast period.


Covid-19 drug delivery devices market data book summary

Market revenue in 2021USD 50.1 million
Market revenue in 2027USD 42.1 million
Growth rate-2.9% (CAGR from 2021 to 2027)
Largest segmentPrefilled syringe
Fastest growing segmentInhalers
Historical data2016 - 2020
Base year2021
Forecast period2022 - 2027
Quantitative unitsRevenue in USD million
Market segmentationPrefilled syringe, Inhalers
Key market players worldwideAstraZeneca PLC ADR, Johnson & Johnson, Serum Institute of India Pvt. Ltd., GSK PLC ADR, Moderna Inc, Pfizer Inc, Bharat Biotech, PHARMAJET, Novavax Inc


Other key industry trends

  • In terms of revenue, South Korea accounted for 2.0% of the global covid-19 drug delivery devices market in 2021.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2027.
  • In Asia Pacific, China covid-19 drug delivery devices market is projected to lead the regional market in terms of revenue in 2027.
  • China is the fastest growing regional market in Asia Pacific and is projected to reach USD 102.7 million by 2027.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

COVID-19 Drug Delivery Devices Market Companies

Name Profile # Employees HQ Website

South Korea covid-19 drug delivery devices market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to covid-19 drug delivery devices market will help companies and investors design strategic landscapes.


Prefilled syringe was the largest segment with a revenue share of 68.86% in 2021. Horizon Databook has segmented the South Korea covid-19 drug delivery devices market based on prefilled syringe, inhalers covering the revenue growth of each sub-segment from 2016 to 2027.


Reasons to subscribe to South Korea covid-19 drug delivery devices market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of South Korea covid-19 drug delivery devices market databook

  • Our clientele includes a mix of covid-19 drug delivery devices market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the South Korea covid-19 drug delivery devices market, including forecasts for subscribers. This country databook contains high-level insights into South Korea covid-19 drug delivery devices market from 2016 to 2027, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

South Korea covid 19 drug delivery devices market size, by product, 2016-2027 (US$M)

South Korea COVID-19 Drug Delivery Devices Market Share, 2021 & 2027 (US$M)

South Korea covid 19 drug delivery devices market size, by product, 2016-2027 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more